BSX Q2 2022 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena

BSXBoston Scientific Corporation

$105B

Q2 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$3.2B+5.4% YoY

Gross Profit

$2.0B61.3% margin

Operating Income

$477M14.7% margin

Net Income

$260M8.0% margin

EPS (Diluted)

$0.17

QoQ Revenue Growth

+7.2%

Cash Flow

Operating Cash Flow

$307M

Free Cash Flow

$202M

Stock-Based Comp.

$55M

Balance Sheet

Total Assets

$32.2B

Total Liabilities

$14.9B

Stockholders' Equity

$17.3B

Cash & Equivalents

$276M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3.2B	$3.1B	+5.4%
Gross Profit	$2.0B	$1.9B	+2.4%
Operating Income	$477M	$511M	-6.7%
Net Income	$260M	$186M	+39.8%

Revenue Segments

Cardiovascular

$2.1B62%

MedSurg

$1.3B38%

Geographic Segments

UNITED STATES

$1.9B60%

Non-US

$1.3B40%